140 results on '"Slavchev, G."'
Search Results
2. HPR134 Ethical Considerations in Pay-for-Performance Programs for Diabetes
3. EE14 Cost Effectiveness of Sensor Augmented Pump Therapy with Automated Insulin Suspension in the Management of Type 1 Diabetes (T1D) in Bulgaria
4. EE8 Еconomic Evaluation of Intravascular Ultrasound (IVUS) for Imaging in Patients with Coronary Artery Disease in Bulgaria
5. EE381 Health Benefits and Cost-Effectiveness Analysis of Early Breast Cancer Diagnosis in Bulgaria
6. RWD181 Improving Clinical Practice and Patient-Centric Care through Digital Outcome Measurement Tools
7. EPH170 Epidemiology of Stroke in Bulgaria
8. HPR1 Bulgaria National Stroke Program: Prevention Strategies
9. OP1 Stroke Treatment Units: Requirements and Recommendations
10. HPR157 Challenges and Potential Solutions in Implementing a Bundle Payment Program for Osteoarthritis
11. EPH115 Primary Prevention Strategies for Stroke: A Multilevel Approach
12. EE291 Budget Impact Analysis of Mrna-1273 (Spikevax) in Patients with COVID-19 in Bulgaria
13. HPR136 Designing an Effective Bundle Payment Program for Osteoarthritis
14. EE161 Economic Burden Associated with Stroke: A Comparative Analysis of Post-Stroke Care Costs
15. HPR5 Implementing a Value-Based Payment Model for Patients with Osteoarthritis
16. HPR90 Global Disparities in P4P Programs for Diabetes Care: A Comprehensive Analysis
17. OP13 Impact of Pay-for-Performance Programs on Diabetes Management: A Critical Analysis
18. HPR180 Evaluating the Success of the National Bundle Payment Program for Osteoarthritis
19. EE47 Cost of Illness Study of Migraine in Bulgarian Patients
20. EE167 Budget Impact Analysis of Sensor Augmented Pump Therapy for Type 1 Diabetes (T1D) in Bulgaria
21. EE324 Clinical and Economic Evaluation of the Potential Implementation of P4P for Type 2 Diabetes in Bulgaria
22. EE377 Budget Impact Analysis of Implementing a Breast Cancer Screening Program in Bulgaria
23. EE526 Health Benefits and Cost-Effectiveness Analysis of Early Cervical Cancer Diagnosis in Bulgaria
24. Economic evaluation and analysis of the budget effect of the measuring of fractional flow reserve in Bulgaria
25. Economic evaluation and analysis of the budget effect of the measuring of fractional flow reserve in Bulgaria
26. EE35 Different Types of Innovative Models for Paying for Gene Therapies - Advantages and Possible Limitations
27. EE308 Budget Impact Analysis (BIA) of Medical Activity on Fractional Flow Reserve Measurement (FFR) for Functional Assessment of Epicardial Stenoses in Patients With Stable Coronary Heart Disease
28. EE26 Costs of Illness of Atypical Hemolytic Uremic Syndrome (aHUS)
29. MSR92 Challenges to Implementing Real-World Evidence (RWE)
30. EE444 Еconomic Evaluation of Medical Activity on Fractional Flow Reserve Measurement (FFR) for Functional Assessment of Epicardial Stenoses in Patients With Stable Coronary Heart Disease
31. EE29 Burden of Disease and Cost of Illness of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Bulgaria
32. EE305 Burden of Disease and Cost of Illness of Atopic Dermatitis (AD)
33. HPR59 Targeted and Immunotherapies for Cancer - Reimbursement and Expenditure in a Single-Payer Healthcare System in Bulgaria
34. POSC225 Challenges Regarding Implementation of Performance-Based Managed Entry Agreements (MEAS) for Advanced Therapy Medicinal Products (ATMPS)
35. POSB225 Differences and Similarities in the Methods: of Pricing of Prescription Drugs in Bulgaria, France, Germany, Belgium, and the UK: A Comparative Analysis
36. POSC285 A Comparative Analysis of Priorities and Methods of Health Technology Assessment (HTA) of Drugs in Selected Countries
37. PCN156 Estimating the Economic and Health IMPACT of the PD-1/PD-L1 Inhibitor CLASS in Bulgaria
38. PGI25 Pharmacoeconomic Evaluation of Drug Therapies for Treatment of Ulcerative Colitis (UC)
39. PCN230 A Systematic Literature Review on Cost-Effectiveness of Next-Generation Sequencing (NGS): NGS Compared to Other High-Throughput Sequencing Methods in the Context of Personalized Cancer Therapy
40. PCN263 Assessment of Comparative Effectiveness of Next Generation Sequencing Versus Standard Diagnostic TESTS in Patients with NON-SMALL CELL LUNG Cancer
41. PIN130 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME/AVIBACTAM FOR THE TREATMENT OF ADULTS WITH COMPLICATED URINARY TRACT INFECTIONS IN BULGARIA
42. PNS362 EQ-5D-5L DATA FOR BULGARIAN POPULATION
43. PIN128 BUDGET IMPACT ANALYSIS OF CEFTAZIDIME/AVIBACTAM FOR THE TREATMENT OF ADULTS WITH COMPLICATED URINARY TRACT INFECTIONS IN BULGARIA
44. PCN142 - COST-EFFECTIVENESS ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA
45. PCN71 - BUDGET IMPACT ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA
46. PGI10 - COMPARATIVE EFFECTIVENESS OF PAN-GENOTYPIC THERAPIES FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C VIRUS INFECTION IN BULGARIA
47. Cost-Effectiveness Analysis of Cladribine Tablets for Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in Bulgaria
48. Cost-Effectiveness Analysis of Palbociclib for the Treatment of Patients with HR+/HER2− Advanced/Metastatic Breast Cancer in Bulgaria
49. Budget Impact Analysis of Palbociclib for the Treatment of Patients With HR+/HER2− Advanced/Metastatic Breast Cancer In Bulgaria
50. Budget Impact Analysis of Tafluprost/Timolol Maleate for Lowering Intraocular Pressure (IOP) in Adult Patients with Open-Angle Glaucoma or Ocular Hypertension in Bulgaria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.